Dr. Hollis C. Reid, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5009 Honeygo Center Dr, Suite 216, Perry Hall, MD 21128 Phone: 410-256-5858 Fax: 410-529-2431 |
News Archive
Nearly a quarter (23%) of all violent crimes are committed by the 2% of people who seriously misuse alcohol or drugs, found a study by Oxford and Swedish researchers in the British Medical Journal.
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Arctic Front® Cardiac CryoAblation Catheter system, the first and only Cryoballoon in the United States indicated for the treatment of drug refractory paroxysmal atrial fibrillation (PAF). The Cryoballoon treatment involves a minimally-invasive procedure that efficiently creates circumferential lesions around the pulmonary vein, which is the source of erratic electrical signals that cause the irregular heartbeat.
Engineered bone marrow grown in a novel microfluidic chip device responds to damaging radiation exposure followed by treatment with compounds that aid in blood cell recovery in a way that mimics living bone marrow.
Doctors and other carers often overlook some important aspects of outcome amongst patients who have suffered head injuries, according to a new study published in BMC Family Practice.
Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for OFIRMEV™ (acetaminophen) injection, the first and only intravenous (IV) formulation of acetaminophen to be approved in the United States. OFIRMEV is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.
› Verified 4 days ago